TipRanks
Go Ultimate55% OFF
PC:ADV46

AdvanCell: Valuation, Funding & Investors

AdvanCell is a biotechnology startup developing targeted alpha therapies for the treatment of prostate cancer. The company is focused on advancing targeted therapeutic approaches and is expanding its U.S. manufacturing infrastructure to support development and scale.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$315M
Total Funding Rounds
1
Latest Funding Amount
$315M
Latest Funding Round
Investment

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jul 17, 2026Investment$315.00M―

Similar Companies

A snapshot of private companies similar to AdvanCell, helping you discover and navigate related company profiles.

Related News and Analysis